Literature DB >> 16052540

Methotrexate for Wegener's granulomatosis: what is the evidence?

Ulrich Specks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16052540     DOI： 10.1002/art.21146

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  3 in total

1.  A phase I trial to evaluate the safety and pharmacokinetics of low-dose methotrexate as an anti-malarial drug in Kenyan adult healthy volunteers.

Authors:  Roma Chilengi; Rashid Juma; Ahmed M Abdallah; Mahfudh Bashraheil; Hudson Lodenyo; Priscilla Nyakundi; Evelyn Anabwani; Amina Salim; Gabriel Mwambingu; Ednah Wenwa; Julie Jemutai; Chemtai Kipkeu; George O Oyoo; Simon N Muchohi; Gilbert Kokwaro; Tim Niehues; Trudie Lang; Alexis Nzila
Journal:  Malar J       Date:  2011-03-16       Impact factor: 2.979

Review 2.  B-cell depletion in Wegener's granulomatosis.

Authors:  Claas H Hinze; Robert A Colbert
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 10.817

3.  Anticancer agents against malaria: time to revisit?

Authors:  Alexis Nzila; John Okombo; Ruy Perez Becker; Roma Chilengi; Trudie Lang; Tim Niehues
Journal:  Trends Parasitol       Date:  2010-01-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.